A program to help women navigate breast cancer care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates a patient navigation program aimed at addressing disparities in breast cancer care for underserved women diagnosed with breast cancer or ductal carcinoma in situ. The program focuses on improving patient knowledge about available clinical and supportive services, helping them navigate these services, and managing barriers to care. By enhancing patients' skills related to cancer treatment management, the program seeks to promote health equity and improve quality of life for newly diagnosed patients over time.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years of age
* Have a confirmed diagnosis of breast cancer or Ductal Carcinoma In Situ (DCIS)
* Currently identify their gender as woman or female
* Was assigned female sex at birth (AFAB)

  \- Participant is experiencing ≥1 barrier to care as determined by the social needs screening tool
* Participant must understand the investigational nature of this study and verbally consent to participate prior to receiving any study related intervention

Exclusion Criteria:

* Participants who are not suspected of or diagnosed with breast cancer or Ductal Carcinoma in Situ (DCIS)
* Participants who have had a previous diagnosis of any cancer
* Participants who were assigned male sex or intersex at birth
* Unwilling or unable to follow protocol requirements

Where it's running

• Roswell Park Comprehensive Cancer Center
  Buffalo, New York, United States Recruiting

Study contacts

• Principal investigator: Kathryn Glaser — Roswell Park Comprehensive Cancer Center
• Study coordinator: Kathryn Glaser
• Email: Kathryn.Glaser@roswellpark.org
• Phone: 716-845-7637

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using low dose tamoxifen with or without omega-3 fatty acids to reduce breast cancer risk

  This study is testing whether adding omega-3 fatty acids to low dose tamoxifen can help reduce the risk of breast cancer in overweight or obese postmenopausal women.

  Recruiting at 3 sites Phase 2 National Cancer Institute (NCI) · Kansas City, Kansas and 2 other locations · NCT06195306

• Finding the best dose of tamoxifen to reduce breast cancer risk in premenopausal women

  This study is testing if a higher dose of tamoxifen can help premenopausal women at higher risk for breast cancer by reducing breast density on mammograms.

  Recruiting at 10 sites Phase 2 National Cancer Institute (NCI) · Tucson, Arizona and 10 other locations · NCT06184750

• Comparing acolbifene and low dose tamoxifen to prevent breast cancer in high-risk premenopausal women

  This study is testing whether acolbifene or low dose tamoxifen can help prevent breast cancer in high-risk premenopausal women.

  Recruiting at 4 sites Phase 2 National Cancer Institute (NCI) · Duarte, California and 3 other locations · NCT05941520

• Mobile health navigation to improve breast cancer screening in Kenyan women

  This study tests m-Health patient navigation tools to help women in Kenya access breast cancer screening and early detection services.

  Recruiting Emory University · Atlanta, Georgia · NCT07764796

• Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression

  This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.

  Recruiting at 11 sites City of Hope Medical Center · Arcadia, California and 10 other locations · NCT07741968

• Environmental exposure checks in high-risk and early-onset breast cancer care

  This study tests how patients and providers feel about using environmental exposure risk data in breast cancer care for women at average/high risk or with early-onset breast cancer.

  Recruiting City of Hope Medical Center · Duarte, California · NCT07690852

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.